Figure 11, Mean A1C Over 24 Weeks During Treatment with Linagliptin versus Placebo - Endotext

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.

This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Endotext [Internet].

This electronic version has been made freely available under a Creative Commons (CC-BY-NC-ND) license. A copy of the license can be viewed at http://creativecommons.org/licenses/by-nc-nd/2.0/.

Cite this Page
Juang PS, Henry RR. Treatment for Type 2 Diabetes. [Updated 2013 Sep 4]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Figure 11, Mean A1C Over 24 Weeks During Treatment with Linagliptin versus Placebo.

Figure 11, Mean A1C Over 24 Weeks During Treatment with Linagliptin versus Place...
Figure 11, Mean A1C Over 24 Weeks During Treatment with Linagliptin versus Placebo - Endotext

Your browsing activity is empty.

Activity recording is turned off.